Compassion Center Austin introduces Texans to natural pain management and opioid risk reduction through the Texas Compassionate Use Program (TCUP)....
LiveWell's app integrates cutting-edge artificial intelligence (AI) and machine learning to provide personalized mental and behavioral health support, fostering user...
KANSAS CITY, Mo. and HEWLETT, N.Y. and PALO ALTO, Calif., Sept. 26, 2024 /PRNewswire/ -- The Brain Cancer Support and Solutions...
meQ Report Explains Vital Strategies to Transform Manager Well-being and Make it an Organizational Priority BOSTON, Sept. 26, 2024 /PRNewswire/...
Annual event highlights big research milestone and further advances benefits of smartwatch-enabled research OLATHE, Kan., Sept. 26, 2024 /PRNewswire/ --...
Jaguar's commercial focus on cancer supportive care aims to use the best tools and techniques that assess the quality of...
ATLANTA, Sept. 25, 2024 /PRNewswire/ -- Medicat, the #1 provider of Electronic Health Records (EHR) software for colleges and universities,...
NEW YORK, Sept. 25, 2024 /PRNewswire/ -- LANGaware, a pioneering AI-driven healthcare technology company, has entered into a strategic partnership...
NORTHAMPTON, MA / ACCESSWIRE / September 25, 2024 / Gilead Sciences As a young gay professional, Terrell Parker spent several...
Policy update increases access for millions covered by HCSC BlueCross BlueShield policiesMALVERN, Pa., Sept. 25, 2024 (GLOBE NEWSWIRE) -- Neuronetics,...
SAN FRANCISCO, CA / ACCESSWIRE / September 25, 2024 / Jaguar Health, Inc. (NASDAQ:JAGX) today announced that Lisa Conte, the...
– Post-hoc analysis from pivotal Phase 3 REST-ON trial confirmed the efficacy of LUMRYZ in study participants who were and...
Provides 23andMe+ Premium members with insight into their likelihood of experiencing emotional eating based on their geneticsSUNNYVALE, Calif., Sept. 25,...
- Demand for mental well-being support becoming widespread - LEXINGTON, Ky., Sept. 25, 2024 /PRNewswire/ -- New research, released today...
The medical technology company supports competitors in the first ever Winter hybrid Invictus GamesBURLINGTON, ON / ACCESSWIRE / September 24,...
The medical technology company supports competitors in the first-ever Winter hybrid Invictus GamesAUSTIN, TX / ACCESSWIRE / September 24, 2024...
The approval of QUVIVIQ™, a novel dual orexin receptor antagonist, is based on robust clinical efficacy and safety data, including...
HCAA's flagship event to provide visionary leadership and industry insights for executive leadership at third-party administrators (TPAs), brokers, and benefit...
CALIFORNIA CITY, CA / ACCESSWIRE / September 23, 2024 / Perfidy has just released a range of new natural help...
The Institute's Collaborative Model with the Center for Incubation & Findings Research (CIFR) and Compassion Center Sets the Stage for...